Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Signs MOU with Taiwan ITRI

6 Aug 2007 07:00

ViaLogy PLC06 August 2007 Date: 6 August 2007 On behalf of: ViaLogy plc ("ViaLogy" or "the Company") Embargoed until: 0700hrs ViaLogy plc Signs Memorandum of Understanding with Taiwan's Industrial Technology Research Institute London, 6 August, 2007 - ViaLogy plc (LSE: VIY), a leading innovator ofreal-time network-centric signal processing platforms, today announces that ithas signed a memorandum of understanding (MOU) with Taiwan's IndustrialTechnology Research Institute (ITRI) to integrate its products, SPMTM andMicroSPMTM, with sensor systems developed by ITRI spin-out companies for uses insafety, security, surveillance and infrastructure management. SPMTM provides a standards-based, sensor-policy engine for managing large-scalenetworks of distributed sensors and systems, including building managementsystems, energy planning and physical security. SPM software allows automatedanalysis, alerting of appropriate personnel and rapid response. MicroSPMTMoffers a high speed hardware platform for fully-autonomous incident-based rapiddetection, analysis and response for sensor and video processing. Using thistechnology, ITRI's products can be enabled to interact rapidly with othernetworked subsystems which support a range of communication protocols. Founded in 1973, ITRI has played a vital role in Taiwan's economic success.Notable ITRI spin-off companies include United Microelectronics Corporation(UMC), the Taiwan Semiconductor Manufacturing Corporation (TSMC), and theVanguard International Semiconductor Company (VIS). Backed by its broadresearch scope and close industrial ties, ITRI is a leader in the globalindustrial R&D community. ITRI has signed research alliances with leadingforeign companies and universities such as Lucent Technologies, Microsoft, MITand the University of California, Berkeley. Michael Kelly, President and CEO of ViaLogy's US subsidiary, commented: "Thiscollaboration is a strategic one for ViaLogy. ITRI has a reputation forcreatively adapting foreign industrial processes to address identified needs andusing these technologies to help its spin-out companies become competitive inworld markets. In today's knowledge-based economy, we believe this cooperationwith ITRI will help position SPM as a comprehensive sensor interoperabilitysolution and service delivery platform for various industries and applicationsacross Asia." Dr. John Mai, ViaLogy's Manager for RFID Platforms, said: "ITRI hasrelationships with the major technology-related businesses in Taiwan. Thiscollaboration will accelerate adoption of SPMTM for large-scale industrialapplications. We are already working on integrating innovative sensor solutionsbeing developed at ITRI to quickly expand and scale up its installed-user base." Dr. Wu Chi Ho, Director of the Power Control and Sensing Application TechnologyDivision, of the Energy and Environmental Research Laboratories within ITRI,commented: "We believe ViaLogy's SPMTM and MicroSPMTM platforms presentexciting solutions to fill gaps in our development and commercialisationprocess. Their IP-enabled sensor interoperability software offers us a path torapidly bring our infrastructure monitoring projects to enterprise-level endusers in the oil and energy market sectors, both within Taiwan andinternationally. "ViaLogy's ability to add new sensors and support new network interoperabilityprotocols within 72 hours is very attractive for our scaling requirements." For further information please contact: ViaLogyMichael Kelly, CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 7869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce LimitedMark Percy +44 (0)20 107 8000 About ITRI: The Industrial Technology Research Institute of Taiwan ITRI is a global, non-profit R&D organisation, engaged in applied research andindustrial services. Founded in 1973, ITRI played a vital role in Taiwan'seconomic success and is leading industrial research to transform Taiwan'seconomy from a manufacturing-based one to that of service- and knowledge- based.Backed by its broad research scope and close industrial ties, ITRI is becomingan increasingly active member in the global industrial R&D community. About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Nov 20207:00 amRNSDirectorate Change
3rd Nov 20207:00 amRNSPartnership with Take2 Health Limited
26th Oct 20207:00 amRNSHalf-year Trading update
23rd Oct 20207:00 amRNSCQC accreditation
21st Oct 20207:00 amRNSYourgene Genomic Services collaboration with Cytox
12th Oct 20207:00 amRNSElucigene DPYD tests to be used routinely in Wales
8th Oct 20207:00 amRNSStrategic reproductive health partnership in Japan
7th Oct 20207:00 amRNSIONA®Nx awarded contract with St George’s Hospital
5th Oct 20207:00 amRNSShare Incentive Plan
1st Oct 20204:59 pmRNSCorrection: Holding(s) in Company
1st Oct 20203:29 pmRNSHolding(s) in Company
28th Sep 20207:00 amRNSLaunch of Yourgene Genomic Services
25th Sep 20205:28 pmRNSIssue of Share Options
24th Sep 202010:00 amRNSDPD reimbursement in Germany
24th Sep 20207:00 amRNSDirector/PDMR Shareholding
23rd Sep 20205:20 pmRNSExercise of Options
23rd Sep 202012:25 pmRNSDirector/PDMR Shareholding
22nd Sep 20205:14 pmRNSResult of AGM
22nd Sep 20207:00 amRNSAGM Statement
21st Sep 20207:00 amRNSUS distribution agreement for DPYD &other products
9th Sep 20207:00 amRNSAGM update and investor presentation
3rd Sep 20207:00 amRNSIONA® Nx Launch
28th Aug 20207:00 amRNSNotice of AGM & Annual Report 2020
13th Aug 20207:00 amRNSTGA approves IONA® Nx for sale in Australia
11th Aug 20207:00 amRNSAdmission of Company Considerations Shares and TVR
7th Aug 20203:42 pmRNSHolding(s) in Company
7th Aug 20203:25 pmRNSHolding(s) in Company
7th Aug 20209:48 amRNSHolding(s) in Company
5th Aug 20201:15 pmRNSResult of Placing
5th Aug 20207:00 amRNS£16.15m Placing & Close of Accelerated Bookbuild
4th Aug 20205:13 pmRNSProposed Acquisition and Placing
3rd Aug 20207:00 amRNSCE-IVD Mark for Clarigene™ SARS-CoV-2 test
29th Jul 202012:05 pmRNSAppointment of Joint Broker
28th Jul 20207:00 amRNSFinal Results
13th Jul 20201:13 pmRNSNotice of Results
30th Jun 20207:00 amRNSCOVID-19 assay launched
19th Jun 20204:44 pmRNSIssue of Share Options
16th Jun 20207:00 amRNSCollaboration in COVID-19 testing
15th Jun 20207:00 amRNSCE-IVD mark received for Illumina-based IONA® test
26th May 202012:00 pmRNSHolding(s) in Company
26th May 20207:00 amRNSCOVID-19 testing service launch; business update
20th May 20207:00 amRNSExercise of Warrants and Options
20th Apr 20207:00 amRNSYear-end Trading update: Revenues increase 86%
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20204:41 pmRNSSecond Price Monitoring Extn
14th Apr 20204:36 pmRNSPrice Monitoring Extension
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSPresentation on ‘Adapting during crisis’

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.